Contact this trialFirst, we need to learn more about you.
Gene Editing Therapy
BEAM-101 for Sickle Cell Disease
Recruiting1 awardPhase 1 & 2
Detroit, Michigan
This trial is testing a new treatment for sickle cell disease, which is a genetic disorder that causes red blood cells to become deformed and break down. The new treatment is called BEAM-101 and it uses a patient's own stem cells that have been edited to fix the genetic mutation that causes sickle cell disease.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service